Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Aleksandra Ogurtsova
PD-L1 Expression in Melanoma: A Quantitative Immunohistochemical Antibody Comparison
Clinical Cancer Research
Cancer Research
Oncology
PD-L1 Expression in Inflammatory Myofibroblastic Tumors
Modern Pathology
Forensic Medicine
Pathology
Related publications
PD-L1 Expression by Tumor Cell-Lines: A Predictive Marker in Melanoma
Experimental Dermatology
Biochemistry
Dermatology
Molecular Biology
P2.06-37 Four Immunohistochemical Assays to Measure the PD-L1 Expression in Malignant Pleural Mesothelioma
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Regorafenib Promotes Anti-Tumor Immunity via Inhibiting PD-L1 and IDO1 Expression in Melanoma
Clinical Cancer Research
Cancer Research
Oncology
Melanoma-Specific MHC-II Expression Represents a Tumour-Autonomous Phenotype and Predicts Response to Anti-Pd-1/Pd-L1 Therapy
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
P3.01-18 Comparison of PD-L1 Immunohistochemical Assays and Clinical Response to Anti PD-1 Checkpoint Inhibitors in Patients With Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
PD-L1 Expression in Triple-Negative Breast Cancer
Cancer immunology research
Cancer Research
Immunology
Nuclear IRF-1 Expression as a Mechanism to Assess “Capability” to Express PD-L1 and Response to PD-1 Therapy in Metastatic Melanoma
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated With Checkpoint Blockade
Cancer immunology research
Cancer Research
Immunology